Helen of Troy (HELE)
(Delayed Data from NSDQ)
$68.04 USD
+1.34 (2.01%)
Updated Oct 18, 2024 03:59 PM ET
After-Market: $68.06 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$68.04 USD
+1.34 (2.01%)
Updated Oct 18, 2024 03:59 PM ET
After-Market: $68.06 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Flowers Foods (FLO) Gains on Acquisitions, Cost Woes Persist
by Zacks Equity Research
Flowers Foods (FLO) is gaining from buyouts and efficient pricing strategy. However, rising production costs are a drag on performance.
Coty Up More Than 35% in 3 Months, Luxury Unit a Key Driver
by Zacks Equity Research
Coty (COTY) gains from strength in its Luxury business. However, challenges in the Consumer Beauty unit persist.
Avon Secures Shareholder Approval for Takeover by Natura
by Zacks Equity Research
Avon's (AVP) efforts to drive productivity, improve brand relevance and digital capabilities bode well.
Procter & Gamble (PG) Up 13% in 6 Months: What's Driving It?
by Zacks Equity Research
Procter & Gamble (PG) is benefiting from ongoing initiatives to improve productivity. Also, the company is focused on product improvement, packaging and marketing initiatives, and cost-saving plans.
Avon Stock Gains 42% on Open Up Initiative & Other Efforts
by Zacks Equity Research
Avon's (AVP) Open Up strategy and productivity efforts appear promising. Also, its endeavors to expand the e-commerce business are driving growth.
Newell Stock Rises 33% on Robust Transformational Gains
by Zacks Equity Research
Newell (NWL) progresses well with the Transformation Plan, which is driving its performance and positioning it well for growth.
International Flavors Rides on Favorable Demand, Costs High
by Zacks Equity Research
The global market for flavors and fragrances continues to grow fueled by rising demand for consumer products, which bodes well for the International Flavors & Fragrances (IFF).
Helen of Troy (HELE) Up 3.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Helen of Troy (HELE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Coty's (COTY) Stock Up More Than 10% on Q1 Earnings Beat
by Zacks Equity Research
Coty (COTY) gains from a strong Luxury unit in first-quarter fiscal 2020. However, the Consumer Beauty unit is weak.
Nu Skin's (NUS) Q3 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Nu Skin's (NUS) third-quarter earnings are affected by limited sales meetings in Mainland China.
International Flavors' (IFF) Q3 Earnings & Sales Lag Estimates
by Zacks Equity Research
International Flavors (IFF) records growth in operating margin and generates strong free cash flow, aided by productivity savings and acquisition-related synergies in Q3.
FEMSA Comercio Seals JV with Raizen, Expands Brazil Footprint
by Zacks Equity Research
FEMSA Comercio, a unit of FEMSA (FMX), closes the previously entered JV agreement with Raizen Conveniencias in Brazil, after receiving the necessary regulatory approvals.
Colgate (CL) Earnings Surpass Estimates in Q3, Sales Miss
by Zacks Equity Research
Colgate (CL) beats third-quarter 2019 earnings estimates on strong volume and pricing gains.
Avon (AVP) Q3 Earnings Beat Estimates, Sales Decline Y/Y
by Zacks Equity Research
Avon's (AVP) focus on pricing and productivity initiatives drives adjusted operating margin. Also, the company is progressing well with its "Open Up Avon" strategy.
Clorox (CLX) Beats Q1 Earnings Estimates, Sales Miss (Revised)
by Zacks Equity Research
Clorox (CLX) reports earnings beat in first-quarter fiscal 2020. However, sales miss estimates on higher trade promotional spending, unfavorable mix, and adverse currency rates.
Clorox (CLX) Beats Earnings & Sales Estimates in Q1 (revised)
by Zacks Equity Research
Clorox (CLX) reports first-quarter fiscal 2020 results on higher trade promotional spending and unfavorable mix as well as adverse currency rates.
Church & Dwight (CHD) Q3 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Church & Dwight's (CHD) Q3 earnings and sales improve on gains from most product categories.
Estee Lauder (EL) Stock Down Despite Q1 Earnings & Sales Beat
by Zacks Equity Research
The Estee Lauder's (EL) first-quarter fiscal 2020 results reflect strength in the Skin Care category, Estee Lauder brand, and travel retail and online channels.
Clorox (CLX) Falls Short Of Earnings & Sales Estimates in Q1
by Zacks Equity Research
Clorox (CLX) reports dismal first-quarter fiscal 2020 results on higher trade promotional spending and unfavorable mix as well as adverse currency rates.
Altria's (MO) Q3 Earnings & Revenues Up Y/Y on Solid Pricing
by Zacks Equity Research
Altria's (MO) performance in third-quarter 2019 gains from improved top-line performance, mainly driven by better pricing.
Hershey (HSY) Q3 Earnings In Line With Estimates, Sales Up
by Zacks Equity Research
Hershey's (HSY) Q3 results benefit from improved volumes and acquisitions. However, currency rates were a drag during the quarter.
Procter & Gamble (PG) Stock Rises on Q1 Earnings & Sales Beat
by Zacks Equity Research
Procter & Gamble's (PG) sales and earnings beat estimates in Q1 on organic sales growth in all segments, margin expansion and cash productivity gains. It raises view for fiscal 2020.
Will Coty's (COTY) Robust Luxury Unit Revive the Stock?
by Zacks Equity Research
Coty (COTY) gains on advancements in its Luxury business and e-commerce platform. However, sluggishness in the Consumer and Professional Beauty segment is a worry.
Helen of Troy (HELE) Q2 Earnings & Sales Beat, Stock Down
by Zacks Equity Research
Helen of Troy Limited's (HELE) top and bottom lines increase year over year and beat the Zacks Consensus Estimate in Q2. However, the Health & Home segment looks troubled.
Will Input Costs Hurt Helen of Troy's (HELE) Q2 Earnings?
by Zacks Equity Research
Helen of Troy's (HELE) Q2 earnings are likely to be hurt by rising costs and weakness in the Personal Care business.